Skip to main content
Top
Published in: Breast Cancer Research 1/2014

Open Access 01-12-2014 | Poster presentation

PB.41. What is the incidence of internal mammary node lymphadenopathy on CT in primary breast cancer patients within 1 year of a diagnosis?

Authors: S Savaridas, J Cox

Published in: Breast Cancer Research | Special Issue 1/2014

Login to get access

Excerpt

The importance of internal mammary nodes (IMNs) in the staging and treatment of breast cancer patients is controversial. Lymphoscintigraphic studies have demonstrated that a significant proportion of breast cancers have primary or partial IMN drainage. However, historical studies demonstrated no overall benefit of treating IMNs with either surgery or radiotherapy. But with recent advances in treatment, targeted radiotherapy of the IMN chain is now possible. Thus we sought to establish the frequency of IMNs within our primary breast cancer population. …
Metadata
Title
PB.41. What is the incidence of internal mammary node lymphadenopathy on CT in primary breast cancer patients within 1 year of a diagnosis?
Authors
S Savaridas
J Cox
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2014
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr3707

Other articles of this Special Issue 1/2014

Breast Cancer Research 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine